[go: up one dir, main page]

Mazar et al., 1999 - Google Patents

The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis

Mazar et al., 1999

View PDF
Document ID
9491354225629484628
Author
Mazar A
Henkin J
Goldfarb R
Publication year
Publication venue
Angiogenesis

External Links

Snippet

Substantial evidence exists which implicates the urokinase plasminogen activator system [urokinase plasminogen activator (uPA), urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1)] in the neo-vascularization, invasion and …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)

Similar Documents

Publication Publication Date Title
Mazar et al. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis
Lin et al. Therapeutics targeting the fibrinolytic system
Romer et al. The urokinase receptor as a potential target in cancer therapy
Mahmood et al. Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): diagnostic, prognostic, and therapeutic applications
Wang The role and regulation of urokinase‐type plasminogen activator receptor gene expression in cancer invasion and metastasis
Sidenius et al. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy
Ossowski et al. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
Mazzieri et al. Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants
Brownstein et al. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages
Testa et al. The role of urokinase-type plasminogen activator in aggressive tumor cell behavior
Wang et al. Ovarian cancer, the coagulation pathway, and inflammation
Andreasen* et al. The plasminogen activation system in tumor growth, invasion, and metastasis
Agarwal et al. Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Mazar The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer
Waltz et al. Nonproteolytic role for the urokinase receptor in cellular migration in vivo
Guo et al. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer
Reijerkerk et al. No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer
Kwaan et al. Pathogenesis of increased risk of thrombosis in cancer
Wojtukiewicz et al. Indirect activation of blood coagulation in colon cancer
Del Rosso et al. The urokinase-type plasminogen activator system and inflammatory joint diseases
Vakili et al. Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active [9–74] processed variant
Reijerkerk et al. Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system
Goldfarb Proteolytic enzymes in tumor invasion and degradation of host extracellular matrices
Fernandes et al. On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells
Kobayashi et al. Role of activated protein C in facilitating basement membrane invasion by tumor cells